Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-88P is a pseudogene copy of the U6 small nuclear RNA (snRNA) gene, specifically the 88th variant identified in the human genome. U6 snRNA itself is a highly conserved, uridine-rich small noncoding RNA component of the spliceosome, a ribonucleoprotein complex essential for excising introns from pre-mRNA via nuclear splicing. However, RNU6-88P represents a non-functional, "dead" copy of this gene—meaning it does not produce active snRNA and is not involved in splicing or any catalytic role. Such pseudogenes are common in the genome due to gene duplication and retrotransposition events, acting as evolutionary relics without biological activity. While U6 snRNA is essential for cell viability and RNA processing, RNU6-88P lacks the critical promoter elements and/or intact coding sequence required for function. There is no evidence that this pseudogene contributes to disease, serves as a drug target, or acts as a biomarker in clinical practice.
None (no mechanisms of drug action are relevant for RNU6-88P)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 88, pseudogene (RNU6-88P).